Literature DB >> 3142784

A new approach to the modification of cell membrane glycosphingolipids: ganglioside composition of JTC-12 P3 cells altered by feeding with galactose as a sole carbohydrate source in protein- and lipid-free synthetic medium.

T Kawaguchi1, T Takaoka, E Yoshida, M Iwamori, K Takatsuki, Y Nagai.   

Abstract

A significant difference in the glycosphingolipid composition of JTC-12 P3 cells established from monkey kidney tissue was observed when cells cultured in a protein- and lipid-free synthetic medium containing glucose (DM-160) as a sole carbohydrate source were transferred and cultured in the same medium containing galactose and pyruvic acid (DM-170) in place of glucose. In particular, the amounts of gangliosides GM3, GM2, and GD3 in the cells cultured in DM-170 were 5.3-, 17.8-, and more than 8-fold those in the cells cultured in DM-160, respectively, indicating that anabolism of gangliosides is greatly enhanced in cells cultured in the presence of galactose and pyruvic acid, as compared with cells cultured in the presence of glucose. In fact, after cultivation of cells in the medium with N-acetyl-D-[14C]mannosamine for 96 h, the radioactivity incorporated into the gangliosides of the cells in DM-170 was 10-fold that of the cells in DM-160. Among the gangliosides of the cells in DM-170, highly sialylated molecules such as GD3, GD1a, GD1b, and GT1b were preferentially labeled, indicating that the sialyltransferases responsible for the synthesis of gangliosides are significantly more activated in cells cultured in DM-170 than in DM-160. These observations reveal that the glycosphingolipid composition of the plasma membrane can be modified epigenetically under well-defined conditions and provide important clues for clarifying the roles of glycosphingolipids associated with particular cell functions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142784     DOI: 10.1016/0014-4827(88)90288-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Altered expression of gangliosides in erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  H Nakakuma; T Kawaguchi; K Horikawa; M Hidaka; Y Yonemura; M Kawakita; T Kagimoto; M Iwamori; Y Nagai; K Takatsuki
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

2.  The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2.

Authors:  J Müthing; J Peter-Katalinić; F G Hanisch; F Unland; J Lehmann
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

3.  Ganglioside alterations in YAC-1 cells cultivated in serum-supplemented and serum-free growth medium.

Authors:  J Müthing; A Pörtner; V Jäger
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

4.  Hemolysis of human erythrocytes is a new bioactivity of gangliosides.

Authors:  K Horikawa; H Nakakuma; S Nagakura; M Kawakita; T Kagimoto; M Iwamori; Y Nagai; T Abe; K Takatsuki
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.